Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

SAN:FP

95.6500 EUR 1.3700 1.41%

As of 11:38:11 ET on 04/17/2015.

Snapshot for Sanofi (SAN)

Open: 97.0500 Day's Range: 95.2300 - 97.6800 Volume: 4,193,622
Previous Close: 97.0200 52wk Range: 69.5800 - 99.2300 1-Yr Rtn: +31.34%

Stock Chart for SAN

No chart data available.
  • SAN:FP 95.6500
  • 1D
  • 1M
  • 1Y
97.0200
Interactive SAN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SAN

Current P/E Ratio (ttm) 28.6377
Estimated P/E(12/2015) 17.0865
Relative P/E vs. CAC 1.1055
Earnings Per Share (EUR) (ttm) 3.3400
Est. EPS (EUR) (12/2015) 5.5980
Est. PEG Ratio 2.4571
Market Cap (M EUR) 126,691.72
Shares Outstanding (M) 1,324.53
30 Day Average Volume 3,043,346
Price/Book (mrq) 2.2487
Price/Sale (ttm) 3.6917
Dividend Indicated Gross Yield 2.98%
Cash Dividend (EUR) 2.8500
Dividend Ex-Date 05/11/2015
5 Year Dividend Growth 4.94%
Next Earnings Announcement 04/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SAN

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for SAN

Sanofi is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.

Olivier BrandicourtChief Executive OfficerElias A ZerhouniPres:Global Research & Dev
Jerome ContamineExec VP/CFODavid-Alexandre GrosExec VP/Chief Strategy Ofcr
More Company Profile & Key Executives for SAN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil